# Imatinib in KIT-negative Systemic Mastocytosis

> **NCT01297777** · PHASE4 · COMPLETED · sponsor: **Hospital Virgen de la Salud** · enrollment: 10 (actual)

## Conditions studied

- Systemic Mastocytosis

## Interventions

- **DRUG:** Imatinib Mesylate

## Key facts

- **NCT ID:** NCT01297777
- **Lead sponsor:** Hospital Virgen de la Salud
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01297777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01297777, "Imatinib in KIT-negative Systemic Mastocytosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01297777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*